Jeffrey H Meyer Selected Research

Monoamine Oxidase (MAO)

1/2022	Imaging of astrocytes in posttraumatic stress disorder: A PET study with the monoamine oxidase B radioligand [11C]SL25.1188.
1/2021	Development and Clinical Application of Positron Emission Tomography Imaging Agents for Monoamine Oxidase B.
1/2019	Classics in Neuroimaging: Development of PET Tracers for Imaging Monoamine Oxidases.
1/2019	Monoamine Oxidase B Total Distribution Volume in the Prefrontal Cortex of Major Depressive Disorder: An [11C]SL25.1188 Positron Emission Tomography Study.
1/2018	Elevated monoamine oxidase A activity and protein levels in rodent brain during acute withdrawal after chronic intermittent ethanol vapor exposure.
1/2018	Corticostriatal Connectivity in Antisocial Personality Disorder by MAO-A Genotype and Its Relationship to Aggressive Behavior.
9/2017	Brain monoamine oxidase B and A in human parkinsonian dopamine deficiency disorders.
1/2017	Subchronic glucocorticoids, glutathione depletion and a postpartum model elevate monoamine oxidase a activity in the prefrontal cortex of rats.
1/2017	Association of monoamine oxidase-A genetic variants and amygdala morphology in violent offenders with antisocial personality disorder and high psychopathic traits.
4/2016	Association of ventral striatum monoamine oxidase-A binding and functional connectivity in antisocial personality disorder with high impulsivity: A positron emission tomography and functional magnetic resonance imaging study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jeffrey H Meyer Research Topics

Disease

28	Major Depressive Disorder (Major Depressive Disorders) 01/2022 - 01/2003
8	Postpartum Depression (Post-Natal Depression) 01/2021 - 05/2010
7	Gliosis 01/2022 - 09/2017
7	Antisocial Personality Disorder (Antisocial Personality) 01/2019 - 10/2015
5	Parkinson Disease (Parkinson's Disease) 01/2021 - 09/2008
5	Mental Disorders (Mental Disorder) 01/2021 - 07/2012
5	Mood Disorders (Mood Disorder) 01/2021 - 08/2014
5	Neuroinflammatory Diseases 12/2020 - 11/2014
3	Alcoholism (Alcohol Abuse) 01/2021 - 05/2014
3	Bipolar Disorder (Manic Depressive Psychosis) 01/2020 - 01/2018
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 03/2012
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2022 - 01/2021
2	Inflammation (Inflammations) 01/2022 - 01/2020
2	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2021 - 01/2020
2	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 11/2008
2	Schizophrenia (Dementia Praecox) 01/2021 - 03/2007
2	Multiple System Atrophy 01/2020 - 09/2017
2	Psychotic Disorders (Schizoaffective Disorder) 01/2018 - 02/2017
2	Borderline Personality Disorder (Personality Disorders, Borderline) 01/2017 - 01/2016
2	Encephalitis (Encephalitis, Rasmussen) 01/2017 - 03/2015
1	Autism Spectrum Disorder 01/2022
1	Anxiety Disorders (Anxiety Disorder) 01/2021
1	Anorexia Nervosa 01/2021
1	Huntington Disease (Huntington's Disease) 01/2021
1	Tourette Syndrome (Tourette's Syndrome) 01/2021
1	Tobacco Use Disorder (Nicotine Dependence) 01/2021
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2021
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2021
1	Substance-Related Disorders (Drug Abuse) 09/2020
1	Treatment-Resistant Depressive Disorder 01/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2019
1	Hypertensive Crisis 01/2019
1	Heroin Dependence (Heroin Abuse) 01/2018
1	Personality Disorders (Personality Disorder) 01/2018
1	Cocaine-Related Disorders (Cocaine Addiction) 01/2018
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 09/2017
1	Parkinsonian Disorders (Parkinsonism) 09/2017
1	Prodromal Symptoms 01/2017
1	Seasonal Affective Disorder 01/2016
1	Anorexia 03/2015
1	Anhedonia 03/2015
1	Weight Loss (Weight Reduction) 03/2015
1	Disease Progression 01/2015
1	Nervous System Diseases (Neurological Disorders) 11/2014
1	Dementia (Dementias) 08/2014
1	Weight Gain 03/2014
1	Disorders of Excessive Somnolence (Hypersomnia) 03/2014
1	Hyperphagia (Overeating) 03/2014
1	Depressive Disorder (Melancholia) 07/2012

Drug/Important Bio-Agent (IBA)

22	Monoamine Oxidase (MAO)IBA 01/2022 - 12/2009
15	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2011
6	Tuberculin (PPD)IBA 01/2021 - 06/2014
6	Antidepressive Agents (Antidepressants)IBA 01/2020 - 03/2007
5	4-aminospiroperidolIBA 01/2019 - 10/2015
4	EnzymesIBA 09/2020 - 11/2012
4	3,4-methylenedioxyethamphetamine (MDEA)IBA 01/2017 - 12/2004
4	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 01/2016 - 03/2007
4	Harmine (Telepathine)IBA 10/2015 - 03/2012
3	SL25.1188IBA 01/2022 - 01/2019
3	Minocycline (Cyclops)FDA LinkGeneric 01/2021 - 01/2020
3	Serotonin (5 Hydroxytryptamine)IBA 09/2020 - 01/2003
3	Pharmaceutical PreparationsIBA 01/2020 - 05/2008
3	AntioxidantsIBA 01/2020 - 01/2018
3	Protons (Proton)IBA 01/2019 - 01/2018
3	Antipsychotic Agents (Antipsychotics)IBA 01/2018 - 01/2015
3	Glutathione (Reduced Glutathione)IBA 01/2018 - 01/2017
2	LigandsIBA 10/2021 - 07/2008
2	CannabinoidsIBA 01/2021 - 01/2021
2	Celecoxib (Celebrex)FDA Link 10/2020 - 01/2020
2	Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor)IBA 09/2017 - 08/2015
2	GlucocorticoidsIBA 01/2017 - 07/2012
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 12/2009 - 09/2007
2	3- amino- 4- (2- dimethylaminomethylphenylsulfanyl)benzonitrileIBA 09/2008 - 09/2007
1	Glial Fibrillary Acidic ProteinIBA 01/2022
1	Hormones (Hormone)IBA 01/2021
1	Biological ProductsIBA 01/2021
1	Opioid Analgesics (Opioids)IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 12/2020
1	Tryptophan (L-Tryptophan)FDA Link 09/2020
1	DinoprostIBA 01/2020
1	C-Reactive ProteinIBA 01/2020
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2020
1	Tetracycline (Achromycin)FDA LinkGeneric 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	Dinoprostone (PGE2)FDA Link 01/2020
1	Cocaine (Cocaine HCl)IBA 01/2018
1	Acetylcysteine (Siran)FDA LinkGeneric 01/2018
1	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 12/2017
1	Oxidoreductases (Dehydrogenase)IBA 09/2017
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2017
1	FluorineIBA 03/2015
1	PK 11195 (PK11195)IBA 01/2015
1	6- (2- methyl- 4- (2- naphthyl)- 1,2,3,4- tetrahydroisoquinolin- 7- yl)pyridazin- 3- amineIBA 06/2014
1	Neurotransmitter Agents (Neurotransmitter)IBA 07/2012
1	beta Adrenergic ReceptorsIBA 11/2008
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 05/2008
1	Dopamine (Intropin)FDA LinkGeneric 03/2007

Therapy/Procedure

3	Therapeutics 01/2021 - 03/2012
1	Precision Medicine 10/2020
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2018